BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2013442)

  • 1. Lack of protective effect of thromboxane synthetase inhibitor (CGS-13080) on single dose radiated canine intestine.
    Barter JF; Marlow D; Kamath RK; Harbert J; Torrisi JR; Barnes WA; Potkul RK; Newsome JT; Delgado G
    Gynecol Oncol; 1991 Mar; 40(3):218-21. PubMed ID: 2013442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1986: Pharmacological, hematological, and physiological effects of a new thromboxane synthetase inhibitor (CGS-13080) during cardiopulmonary bypass in dogs. Updated in 1994.
    DeAnda A; Miller DC
    Ann Thorac Surg; 1994 Mar; 57(3):778-80. PubMed ID: 7511885
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological, hematological, and physiological effects of a new thromboxane synthetase inhibitor (CGS-13080) during cardiopulmonary bypass in dogs.
    DeCampli WM; Goodwin D; Kosek JC; Handen CE; Mitchell RS; Miller DC
    Ann Thorac Surg; 1986 Dec; 42(6):690-6. PubMed ID: 3789860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury.
    Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR
    J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CGS 12970: a novel, long acting thromboxane synthetase inhibitor.
    Ambler J; Butler KD; Ku EC; Maguire ED; Smith JR; Wallis RB
    Br J Pharmacol; 1985 Oct; 86(2):497-504. PubMed ID: 2932197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of inhibition of thrombin and blockade of thromboxane A2 synthetase and receptors enhances thrombolysis and delays reocclusion in canine coronary arteries.
    Yao SK; Ober JC; Ferguson JJ; Anderson HV; Maraganore J; Buja LM; Willerson JT
    Circulation; 1992 Dec; 86(6):1993-9. PubMed ID: 1451271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low-dose aspirin and specific thromboxane synthetase inhibition on whole blood platelet aggregation and adenosine triphosphate secretion in healthy dogs.
    Grauer GF; Rose BJ; Toolan L; Thrall MA; Colgan SP
    Am J Vet Res; 1992 Sep; 53(9):1631-5. PubMed ID: 1416368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of thromboxane synthetase inhibition to protect the postinfarcted heart against the induction of ventricular tachycardia and ventricular fibrillation in a conscious canine model of sudden coronary death.
    Kitzen JM; Lynch JJ; Uprichard AC; Venkatesh N; Lucchesi BR
    Pharmacology; 1988; 37(3):171-86. PubMed ID: 3227051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of thromboxane synthetase inhibitor and methylprednisolone effects on protamine responses in dogs.
    Fomsgaard JS; Kim YD; Burke TA; Viswanathan T; Schaffer AV; Peppard J; Douglas FL; Danchak M; Myers AK
    Anesth Analg; 1992 Jan; 74(1):38-43. PubMed ID: 1734796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models.
    Ku EC; McPherson SE; Signor C; Chertock H; Cash WD
    Biochem Biophys Res Commun; 1983 May; 112(3):899-906. PubMed ID: 6687803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations.
    Yao SK; Rosolowsky M; Anderson HV; Golino P; NcNatt JM; De Clerck F; Buja LM; Willerson JT
    J Am Coll Cardiol; 1990 Sep; 16(3):705-13. PubMed ID: 2143767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal and maternal response to intravenous infusion of a thromboxane synthetase inhibitor.
    Cardin JP; Ross MG; Ervin MG; Schaffer AV; Douglas FL; Simke JP
    Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1345-9. PubMed ID: 2220946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of CGS 13080, a thromboxane synthase inhibitor, in suppressing serum and urine immunoreactive thromboxane B2 in kidney transplant patients.
    Foegh ML; Lim K; Douglas F; Turk J; Helfrich GB; Taher SA; Alijani MR
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):424-7. PubMed ID: 3279631
    [No Abstract]   [Full Text] [Related]  

  • 16. Biology and biochemistry of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():235-40. PubMed ID: 6221529
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
    Vaghi F; Colombo M; Pierucci L; Volpi D; Dho L; Ukmar G; Rosa B; Salvati P
    Drugs Exp Clin Res; 1993; 19(6):249-60. PubMed ID: 8013268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of pulmonary thromboxane A2 synthase activity and airway responses by CGS 13080.
    McNamara DB; Harrington JK; Bellan JA; Graybar GB; Underwood DC; Kadowitz PJ
    Mol Cell Biochem; 1989 Jan; 85(1):29-41. PubMed ID: 2725478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective and nonselective inhibition of thromboxane formation.
    FitzGerald GA; Oates JA
    Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ischemic skin flap elevation on tissue and plasma thromboxane A2 and prostacyclin production: modification by thromboxane synthetase inhibition.
    Edstrom LE; Balkovich M; Slotman GJ
    Ann Plast Surg; 1988 Feb; 20(2):106-11. PubMed ID: 3281544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.